10/18/2024

Janusmed sex and gender

Janusmed sex and gender – eculizumab

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Eculizumab

Eculizumab

Class : B

  1. Food and Drug Aministration (FDA). Clinical Pharmacology and Biopharmaceutics Review - SOLIRIS (eculizumab). Food and Drug Administration [www]. [updated 2007-05-17, cited 2017-03-20].
  2. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2016 [cited 2017-03-23.]